Bill
S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026
119th Congress
Introduced by James Lankford and 2 co-sponsors
Reauthorizes federal stem cell research funding and updates clinical oversight regulations through 2030s to balance scientific advancement with ethical and safety standards.
Introduced in Senate